Drug Interactions Between Metronidazole/Amoxicillin and Tacrolimus/Mycophenolate Mofetil
Direct Answer
Metronidazole combined with norfloxacin significantly reduces mycophenolate mofetil exposure by 33%, but metronidazole alone does not significantly affect MMF levels, and neither metronidazole nor amoxicillin have clinically significant interactions with tacrolimus. 1
Mycophenolate Mofetil (MMF) Interactions
Metronidazole
When metronidazole is given alone with MMF, there is no significant effect on mycophenolic acid (MPA) exposure. 1 The FDA label specifically states that when MMF was administered with metronidazole separately (not in combination with norfloxacin), the mean MPA AUC was 42.7 (± 23) mcg•h/mL compared with 56.2 (± 24) mcg•h/mL for MMF alone—a non-significant reduction. 1
However, the combination of norfloxacin plus metronidazole significantly reduces MPA exposure by 33% and is not recommended. 1 This interaction occurs through antibiotic-induced reduction of glucuronidase-possessing enteric organisms, leading to decreased enterohepatic recirculation of MPA. 1
Research confirms this FDA guidance: a study in 11 healthy volunteers showed MPA AUC reductions of 10% with norfloxacin alone, 19% with metronidazole alone (non-significant), and 33% with the combination (significant). 2
Amoxicillin
Amoxicillin plus clavulanic acid causes approximately 50% reductions in median trough MPA concentrations within 3 days of starting therapy. 1 In 64 renal transplant recipients, these reductions tended to diminish within 14 days of continued antibiotic therapy and ceased within 3 days after discontinuation. 1 The mechanism is identical to metronidazole—disruption of gut flora reduces enterohepatic recirculation of MPA. 1
Clinical relevance remains unclear because trough levels may not accurately represent overall MPA exposure. 1
Clinical Management for MMF
- Monitor MPA trough levels closely when starting amoxicillin-clavulanate, with measurements at days 3-7 and again at 14 days if therapy continues. 1
- Avoid the combination of norfloxacin plus metronidazole entirely with MMF. 1
- Metronidazole monotherapy can be used with MMF without dose adjustment, though monitoring remains prudent. 1
- Consider temporary MMF dose increases if trough levels drop significantly with amoxicillin-clavulanate, but recognize levels typically normalize within 2 weeks or 3 days post-antibiotic. 1
Tacrolimus Interactions
Metronidazole
Metronidazole does not cause clinically significant increases in tacrolimus levels despite two historical case reports suggesting otherwise. 3 A retrospective study of 52 solid organ transplant patients with Clostridium difficile infection found no significant difference in dose-normalized tacrolimus levels between metronidazole (n=35) and vancomycin (n=17) treatment groups. 3 The mean difference between groups was 0.96 (95% CI: 0.74-1.24), indicating no clinically meaningful interaction. 3
Both metronidazole and vancomycin treatment groups required similar tacrolimus dose adjustments to maintain therapeutic levels, suggesting the diarrheal illness itself—not the antibiotic—affects tacrolimus absorption. 3
Amoxicillin
No documented interaction exists between amoxicillin and tacrolimus. Tacrolimus is metabolized by cytochrome P450 3A enzymes, and amoxicillin does not inhibit or induce this system. 4 The primary concern with tacrolimus is drugs that affect CYP3A (such as azole antifungals, macrolides, and rifampin), which amoxicillin does not. 4
Clinical Management for Tacrolimus
- Use standard tacrolimus monitoring (trough levels) when prescribing metronidazole or amoxicillin. 3
- Attribute tacrolimus level fluctuations during gastrointestinal infections to the illness itself (diarrhea, altered absorption) rather than antibiotic interactions. 3
- Focus vigilance on known CYP3A inhibitors (erythromycin, clarithromycin, azole antifungals) and inducers (rifampin) rather than metronidazole or amoxicillin. 5, 4
Key Caveats
Drugs that alter gastrointestinal flora can interact with MMF by disrupting enterohepatic recirculation, but this effect varies by antibiotic and is often transient. 1 The FDA label warns that interference with MPAG (mycophenolic acid glucuronide) hydrolysis leads to less MPA available for absorption. 1
The combination of immunosuppression with antibiotics increases infection risk independent of drug interactions. In transplant guidelines, MMF combined with tacrolimus shows infection rates of 36% (including 14% CMV), which clinicians must balance against rejection prevention. 6, 7
Renal function affects both tacrolimus and MMF metabolism, creating additional complexity when antibiotics are needed for infections that may themselves impair kidney function. 6, 1